Table 2.
| Clinical Situation | Empiric antibiotic therapy | Dosage |
|---|---|---|
| Community-acquired |
ceftriaxone plus ampicillina (plus vancomycinb) |
2x2g/day i.v. 6x2g/day i.v. 2x1g/day i.v. (check serum concentration) |
| Nosocomial |
Meropenem plus vancomycin alternative option: ceftazidime plus vancomycin |
3x2g/day i.v. 2x1g/day i.v. (check serum concentration) 3x2g/day i.v. 2x1g/day i.v. (check serum concentration) |
| Immunocompromised patients |
ceftriaxone plus ampicillin plus vancomycinb |
2x2g/day i.v. 6x2g/day i.v. 2x1g/day i.v. (check serum concentration) |
aIn case of penicillin allergy, the use of meropenem is recommended instead (3x2g/day i.v)
bIn case of a high prevalence of S. pneumoniae that are resistant to 3rd generation cephalosporines (see recommendations of local authorities). As an alternative to vancomycin, rifampicin (1x600mg/day i.v.) can be administered